Procaps Group, S.A. (PROC): Price and Financial Metrics
GET POWR RATINGS... FREE!
PROC Stock Price Chart Interactive Chart >
PROC Price/Volume Stats
|Current price||$8.63||52-week high||$11.98|
|Prev. close||$8.63||52-week low||$5.86|
|Day high||$8.90||Avg. volume||32,343|
|50-day MA||$8.26||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||973.64M|
Procaps Group, S.A. (PROC) Company Bio
Procaps Group, S.A. develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and clinical solutions. It operates in 13 countries in Latin America. The company was founded in 1977 and is based in Luxembourg City, Luxembourg
Most Popular Stories View All
PROC Latest News Stream
|Loading, please wait...|
PROC Latest Social Stream
View Full PROC Social Stream
Latest PROC News From Around the Web
Below are the latest news stories about Procaps Group SA that investors may wish to consider to help them evaluate PROC as an investment opportunity.
Investment company Sagil Capital LLP (Current Portfolio) buys iShares MSCI Emerging Markets ETF, Ternium SA, Petroleo Brasileiro SA Petrobras, GeoPark, Ecopetrol SA, sells Vinci Partners Investments, Itau Unibanco Holding SA, Enel Americas SA, XP Inc, Credicorp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Sagil Capital LLP.
Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida
MIAMI, February 02, 2022--Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida
BARRANQUILLA, Colombia, January 28, 2022--Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director
Procaps Group Acquires 1st U.S.-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit
BARRANQUILLA, Colombia, January 12, 2022--Procaps Group Acquires 1st U.S.-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit
The big shareholder groups in Procaps Group, S.A. ( NASDAQ:PROC ) have power over the company. Generally speaking, as a...
PROC Price Returns